Mirum Pharmaceuticals MIRM

$ 41.86 1.76%

Quarterly report 2024-Q3
added 11-12-2024

Mirum Pharmaceuticals Financial Statements 2011-2024 | MIRM

Annual Financial Statements Mirum Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	1.09 B	800 M	484 M	473 M	194 M	-	-	-	-	-	-	-	-
Shares	40.9 M	33.8 M	30.3 M	26.1 M	11.5 M	-	-	-	-	-	-	-	-
Historical Prices	26.8	23.6	15.9	17.5	24.5	-	-	-	-	-	-	-	-
Net Income	-163 M	-136 M	-84 M	-103 M	-52.6 M	-	-	-	-	-	-	-	-
Revenue	186 M	77.1 M	19.1 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-109 M	-131 M	-173 M	-104 M	-54.7 M	-	-	-	-	-	-	-	-
Interest Expense	-2.82 M	365 K	-582 K	-192 K	-21 K	-	-	-	-	-	-	-	-
EBITDA	-98.3 M	-128 M	-173 M	-104 M	-54.4 M	-	-	-	-	-	-	-	-
Operating Expenses	296 M	208 M	193 M	104 M	54.7 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	146 M	89.1 M	59.2 M	22.7 M	11.8 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Mirum Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	47.8 M	47.2 M	46.9 M	46.7 M	41.1 M	38.1 M	37.7 M	37 M	34.9 M	32.2 M	31.3 M	30.6 M	30.4 M	30.3 M	30.1 M	29.8 M	25.1 M	25.1 M	24.7 M	22.6 M	18 M	2.55 M	2.52 M	637 K	477 K	637 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-14.2 M	-24.6 M	-25.3 M	-	-23.6 M	-74 M	-30.1 M	-	-35.7 M	-26.9 M	-36.6 M	-	-47.1 M	-43.9 M	-50.5 M	-	-21.5 M	-23.3 M	-21.3 M	-	-15.1 M	-13.6 M	-5.96 M	-	-67 K	-10 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	90.4 M	77.9 M	69.2 M	-	47.7 M	37.5 M	31.6 M	-	18.8 M	17.5 M	12.9 M	-	5 M	11 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-12.7 M	-24.2 M	-26.5 M	-	-25.1 M	-24.3 M	-27.1 M	-	-32.9 M	-31.4 M	-32.7 M	-	-42.8 M	-37.4 M	-47.6 M	-	-21.7 M	-23.6 M	-22 M	-	-15.9 M	-14 M	-6.18 M	-	-65 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-1.09 M	312 K	1.76 M	-	1.32 M	-274 K	-811 K	-	-192 K	1.3 M	-154 K	-	-35 K	-514 K	-16 K	-	-30 K	-56 K	-23 K	-	-5 K	9 K	-5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-6.78 M	-18.5 M	-20.8 M	-	-22.5 M	-23 M	-25.8 M	-	-31.9 M	-30.9 M	-32.4 M	-	-42.6 M	-37.4 M	-47.5 M	-	-21.5 M	-23.5 M	-22 M	-	-15.8 M	-14 M	-6.18 M	-	-65 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	103 M	102 M	95.7 M	-	72.9 M	61.8 M	58.7 M	-	51.7 M	48.9 M	45.6 M	-	47.8 M	48.4 M	47.6 M	-	21.7 M	23.6 M	22 M	-	15.9 M	14 M	6.18 M	-	65 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	50.5 M	49.2 M	45.6 M	-	36.5 M	32.9 M	30.2 M	-	22.5 M	21 M	19.1 M	-	17.4 M	13.4 M	9.48 M	-	5.73 M	5.04 M	4.69 M	-	3.71 M	2.44 M	1.32 M	-	62 K	10 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency